Under the agreement, Mayo Clinic will invest a minority stake in the company and nominate a member to the board of directors of Karkinos, according to a May 22 press release.
Karkinos Healthcare, based in India, uses a technology platform to detect and diagnose common cancers.
The company works with healthcare institutions and professionals in oncology.
